Revance Therapeutics Inc. (RVNC) Dipped -5.69% or -1.75 To Price $29.0 On Monday


Revance Therapeutics Inc. (RVNC) dipped -5.69% or -1.75 to $29.0. It is nearly 509355 shares traded, which is 140.46% compare to the average total volume 362625. The market cap of RVNC is $1.07 billion. The year to date change is -23.47%. The 52 week price range is from $22.05 to $37.45. Price of RVNC have changed 0.33% during last week. It have changed 0.00% over last month, 0.49% over last 3 months, -13.87% over last 6 months and 14.10% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RVNC is 29.99. It is 3.41% above current price. The 200-day Moving Averages for RVNC is 29.91. It is 3.14% above current price. The 52-week High is 37.45. It is 29.14% from the current price. The 52-week Low is 22.05. It is -23.97% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RVNC is 9.85 on 2018-05-31. Short % to float is 7.50%. There are some statistics of RVNC. It is has market cap $1.07 billion. The share outstanding is 36.78 million. The average volume is 362625. The revenue is 150000. The percent of top 15 Institution holding is 88.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RVNC is -61.87%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RVNC is -51.99%.


Tags:

Share this post